A retrospective NIS to evaluate the use of Seroquel XR and IR in the clinical practice of outpatients with schizophrenia

Study identifier:NIS-NDK-SER-2010/2

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A retrospective, non-interventional study to evaluate the use of Seroquel XR and Seroquel IR in the clinical practice of outpatients with schizophrenia

Medical condition

schizophrenia

Phase

-

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

186

Study type

Observational

Age

18 Years - 65 Years

Date

Study Start Date: 01 Oct 2010
Primary Completion Date: 01 Feb 2011
Study Completion Date: 01 Feb 2011

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Mar 2011 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria